ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Ovarian cancer is a complex disease associated with multiple genetic and epigenetic alterations. The emergence of treatment resistance in most patients causes ovarian cancer to become incurable, and novel therapies remain necessary. We identified epigenetic regulator ATPase family AAA domain-containing 2 (ATAD2) is overexpressed in ovarian cancer a...
Alternative Titles
Full title
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_65c81d8f41da468297d0844b5876e63c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65c81d8f41da468297d0844b5876e63c
Other Identifiers
ISSN
2041-4889
E-ISSN
2041-4889
DOI
10.1038/s41419-023-05993-9
